baber/WOPTO huggingface dataset:
Patent NZ-228756-A (NZ)
Title: Detection of hiv antigen using competition immune assay or western blot assay
Inventor: GALLO ROBERT C
IPC: G01N33/53
Filed: 1985-04-22
Abstract: Production of core antigens of the virus HTLV-III and their use in detection of antibodies in sera of AIDS and pre-AIDS patients, and to biochemical and immunological analysis of antigens associated with the virus HTLV-III. The utilization of p24 and p41 core antigens enables a greater specificity of detection. It is shown that antigens associated with the infection of human cells by the virus are specifically recognized by antibodies from AIDS patients. Specifically, HTLV-III isolated from AIDS patients and transformed by occultivation with an HT cell line is specifically detected by antibodies from human sera taken from AIDS patients. The p24 and p41 antigens are used to monitor the precense of HTLV-III in cultured cells and cell-free culture fluids, where virus infection is suspected, and also to monitor antibodies in human sera. The method of detection of antibodies preferred is a radioimmunoassay (RIA), ELISA (an enzyme-linked immuno-sorbent assay) or indirect immunofluorescene assay.
Patent NZ-252340-A (NZ)
Title: Pulp digestor with polygonal screen forming sealed volume inside digestor for isothermal continuous cooking throughout digestor
Inventor: BACKLUND AKE
IPC: D21C3/24
Filed: 1993-04-08
Abstract: Continuous upright fibrous material digester, has top input for material and cooking liquor and a bottom liquor withdrawal screen below at least one lower half further screen having at least one screen element (2A) of angular shape, for preference rectangular and square of area below 1 m2. The screen face (3A) of the element is attached to the digester wall (1A) in manner to form a sealed vol. (V) with an inlet and outlet pipe (15) through the wall (1A). Pref. the element (2A) is assembled by welding and mounted in the wall (1A) by welding (9), and is on bars (4) supported by shoulders (7).
Patent NZ-268038-A (NZ)
Title: Gene coding for intracellular binding protein (tbp) defective recombinant virus containing the gene, compositions
Inventor: SCHWEIGHOFFER FABIEN
IPC: C07K16/10
Filed: 1994-06-15
Abstract: PCT No. PCT/FR94/00714 Sec. 371 Date Dec. 28, 1995 Sec. 102(e) Date Dec. 28, 1995 PCT Filed Jun. 15, 1994 PCT Pub. No. WO94/29446 PCT Pub. Date Dec. 22, 1994The present invention relates to nucleic acid sequences encoding intracellular binding proteins. More particularly, the nucleic acid comprises a gene coding for an intracellular single chain antibody specific for a ras oncogene under the control of a promoter, the antibody is functional in mammalian cells, and inhibits the transformation of cells that express a ras oncogene.
Patent NZ-280404-A (NZ)
Title: Composite film for vacuum skin packaging having a permeable film with semi-adherent layer using the film, film details
Inventor: MIRANDA NATHANAEL R
IPC: B32B27/08
Filed: 1995-11-06
Abstract: A composite film and vacuum skin package for packaging a product such as a fresh red meat is disclosed. The composite film is thermoformed and sealed under vacuum to a support member to completely enclose a product which is positioned on the support member. The composite film is a permeable film weakly bonded to an impermeable film, permitting the impermeable film to be peeled from the package while leaving the permeable film intact so that the fresh red meat product can bloom from a purplish color to a desirable red color upon exposure to oxygen. The permeable and impermeable films are fully peelable without the need for a migratable wax to enhance peelability. <IMAGE>
Patent NZ-313079-A (NZ)
Title: Electronic electricity meter, performs diagnostic tests, and automatically detects nature of electrical service
Inventor: BRIESE FOREST
IPC: G01R35/04
Filed: 1996-07-22
Abstract: n integral electronic electricity meter system diagnostics package includes a microprocessor 44, and storage memory 45.  The meter can be programmed to perform a pre-selected series of system diagnostic tests, recording any results which exceed predefined programmable thresholds.  A display 33 displays error and/or diagnostic messages identifying selected diagnostic data and/or errors discovered in the meter tests during a predefined period. The system includes logic for automatically sensing the type of electrical service to which the meter is attached.
Patent NZ-331371-A (NZ)
Title: Crystal modification of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide and use thereof
Inventor: PORTMANN ROBERT
IPC: C07D249/04
Filed: 1998-06-08
Abstract: The specification describes the modification A or A' of the compound 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide of formula (I), its use for the treatment of epilepsy, and pharmaceutical preparations comprising this crystal modification.
Patent NZ-333653-A (NZ)
Title: use of milk anti-inflammatory factor to inhibit an inflammatory response and/or neutrophil migration
Inventor: BECK LEE R
IPC: A61K35/54
Filed: 1995-09-08
Abstract: A milk anti-inflammatory factor obtained from skim milk by: a) ultrafiltering the milk through a filter with a molecular weight cut-off of 10,000 Daltons; b) collecting a < 10,000 permeate from step a); c) applying the permeate to a first ion exchange column and washing the column with deionized water; d) collecting the eluate from step c); e) separating the eluate from step d) on a preparative size exclusion HPLC chromatography column and collecting the eluate and f) performing organic partition extraction of the eluate obtained from the preparative size exclusion HPLC chromatography and obtaining the organic extract from the extraction is used in the manufacture of a medicament for use in i) inhibiting neutrophil migration in a mammal, ii) inhibiting an inflammatory response in a mammal, iii) inhibiting neutrophils from adhering to endothelial cells in a mammal, iv) detaching neutrophils which have adhered to endothelial cells in a mammal, v) inhibiting the interaction between CD-18 cell surface antigens and molecules which are capable of binding to the antigens in a mammal, vi) inhibiting the emigration of leukocytes from the venous system of a mammal and vii) suppressing the mitogenic response of lymphocytes to foreign antigens in a host mammal
Patent NZ-336006-A (NZ)
Title: Coating material for absorbing solar energy characterised in the coat consisting of aqueous dispersions (acrylate, styrene), solvent containing binding agent (acryl), thermoplastic materials, metals and alloys (Al, Al-bronze, An, Cr, Pd, Pt) and electrically non-conducting materials (Mo, Fe, Au, Zn)
Inventor: HUGO GERD
IPC: B05D7/24
Filed: 1997-12-03
Abstract: A coating material is provided which encompasses: (a) A binding agent with a large transparency of at least 30% in the range of visible light from 0.35 to 0.7 mm and with at least 20% in the range of the thermal infrared from 5-25 mm; (b) First particles which and/or backscatter reflect in the wavelength range of the thermal infrared from 5-25 mm; (c) Second particles which reflect and/or backscatter in the wavelength range of visible light from 0.35 to 0.7 mm and have a transmission in the wavelength range of the thermal infrared from 5 to 25 mm of > 20%, preferably > 40%; (d) Third particles which are electrically conducting and have a low absorption in the range of the thermal infrared from 5-25 mm of < 80%, preferably < 60%. The coating material is to be used to save energy in houses and buildings. The coating materials used in the exterior and/or interior could absorb solar energy without emitting in the long-wave range of the thermal infrared.
Patent NZ-336134-A (NZ)
Title: Bicyclic inhibitors of protein farnesyl transferase for treatment of cancer, restenosis and atherosclerosis
Inventor: DOBRUSIN ELLEN MYRA
IPC: C07D233/68
Filed: 1998-02-11
Abstract: A method of treating and/or preventing cancer, restenosis or atherosclerosis using the compounds of the general Formula (I), (II), (III), (III) and (IV). Wherein; Q is O, -NOR, -N-NRR, -NOCH2CO2Ra, Formula (A), Formula (B) or Formula (C); L is hydrogen, Formula (D) or Formula (E); Ra or Rb is independently hydrogen, C1-6alkyl, C2-6alkenyl, phenyl, or substituted phenyl, or Ra and Rb along with the carbon atom to which they are bonded form a C3-6cycloalkyl ring; R is independently hydrogen, C1-6alkyl, C3-6cycloalkyl, benzyl, C2-6alkenyl, phenyl, or substituted phenyl; Each ---is a bond or absent; P is N, -CR, Formula (F), -C-E', Formula (G), or Formula (H); X is CH2, CH2O, CH2S, CH2SO, CH2SO2, CH2NR, or Formula (I); E' is independently hydrogen, halogen, -NO2, -NRR, -R, -OR, Formula (J), Formula (K), -O-(CH2)nE, -NR(CH2)nE, -CO2R, -CONRR,  Formula (L), Formula (M), Formula (N), C1-6alkyl, C2-6alkenyl, benzyl, substituted benzyl, phenyl or substituted phenyl; n is independently 0 to 5 inclusive; a is independently 0, 1 or 2; m is 0, 2, 3, 4 or 5; Y is CH2, NR, O, SO, SO2 or S; B is pyrrolyl, substituted pyrrolyl, imidazolyl, substituted imidazolyl, oxazolyl, substituted oxazolyl, thiazolyl, substituted thiazolyl, Formula (O), Formula (P), Formula (Q), -NR1-(CH2)n-(CHX3)-(CH2)n-SR1, -S-(CH2)n-(CHX3)-(CH2)n-SR1, or -(CH2)n-(CHX3)-(CH2)n-SR1.
Patent NZ-501361-A (NZ)
Title: Raised road marker with venting groove for enhanced bonding with adhesive
Inventor: GREEN JOHN L
IPC: E01F9/06
Filed: 1998-05-08
Abstract: A raised road marker (200) has a flat bottom surface with an outer periphery. At least one cavity (214, 216) opens onto the bottom surface laterally inwardly of the periphery and extends upwardly into the marker body. A venting groove (218) extends along the bottom surface from the cavity (214, 216) to the periphery to provide a vent for air trapped in the cavity (214, 216) when the marker is urged into a pool of adhesive to secure the marker to a roadway. The venting of air provides a stronger bond between the marker and adhesive. Markers having a rounded top surface (202) may be provided with a flat bottom portion (204) with abutment surfaces (210) to facilitate movement of a line of the markers in an automated system.
Patent NZ-501650-A (NZ)
Title: Use of a pADPRT inhibitory compound that is not 3-aminobenzamide to treat inflammation and inflammatory diseases in mammals
Inventor: KUN ERNEST
IPC: C07D311/08
Filed: 1998-05-13
Abstract: Described is a method of treating inflammation or inflammatory disease, bacterial infection, arthritis and stroke in an animal or mammal, which comprises the steps of administering an effective amount of a pADPRT inhibitory compound. The pADPRT inhibitory compound is selected from the group consisting of formulas (I), (II), (III) wherein, R1, R2, R3, R4, R5 and R6 are each selected from the group consisting of hydrogen, hydroxy, amino, alkyl, alkoxy, cycloalkyl or phenol, optionally substituted with alkyl, alkoxy, hydroxy or halo, and only one of R1, R2, R3, R4, R5 and R6 is amino in the manufacture of a medicament for treating inflammation or inflammatory diseases.
Patent NZ-502358-A (NZ)
Title: Hydrogel composition comprising a biologically active substance combined with a macromer
Inventor: HUBBELL JEFFREY A
IPC: A61K9/22
Filed: 1998-07-17
Abstract: Disclosed is a method for delivering a biologically active substance including the steps of: (a) combining said biologically active substance with a macromer; (b) forming a mixture of the combination formed in step (a); (c) polymerising said mixture to form articles; and (d) administering said articles, or a portion thereof, to a mammal, where step (c) takes place in the absence of a polymerisable monovinyl monomer.
Patent NZ-503694-A (NZ)
Title: Animal identification tag with mating sections to enclose transponder and having respective pins to locate , without force, against nasal septum of animal
Inventor: JOHNSON MICHAEL JEFFREY
IPC: A01K11/00
Filed: 1998-09-25
Abstract: An animal identification tag consisting essentially of only two parts which co-operate to form a receptacle for a transponder. For instance one part (2) may form a receptacle (6) in the form of an undercut slot and the other part (3) may act as a cover for the receptacle. A locking ramp and groove on the internal faces of slot and cover may act to lock the parts when the cover is fully slid into the slot. This locking will also act to lock opposing pins (4, 5) about the nasal septum of an animal, e.g. a cow.
Patent NZ-511478-A (NZ)
Title: Compounds useful in the treatment of inflammatory diseases
Inventor: BROWN DAVID
IPC: C07K5/065
Filed: 1999-12-16
Abstract: A compound of formula (I), wherein: R1 and R2 are C1-6alkyl, C3-8cycloalkyl or C1-3alkylC3-8cycloalkyl, or NR1R2 together form an optionally substituted nitrogen containing heterocyclic ring, R3 is substituted C1-6alkyl and C2-6alkenyl groups and derivatives, R4 represents hydrogen, C1-6alkyl and derivatives, R5 represents hydrogen of C1-6alkyl, or R4R5 together form a C5-7cycloalkyl ring, The compounds of formula (I) are used in the manufacture of medicaments for the treatment of inflammatory diseases.
Patent NZ-514427-A (NZ)
Title: Needleless syringe
Inventor: BELLHOUSE BRIAN JOHN
IPC: A61M5/30
Filed: 2000-03-14
Abstract: A needleless syringe capable of accelerating particles into a target surface is provided. The syringe comprises a body (20, 21, 22) having a lumen with a diaphragm (26) located adjacent to a terminus thereof. Particles are delivered from an external surface of the diaphragm (26) by means of the motive force provided by the impact of a shockwave imparted to the internal surface of the diaphragm. A method for delivering particles from the needleless syringe is also provided
Patent NZ-516959-A (NZ)
Title: An oral controlled drug delivery system in the form of a multiparticulate or monolithic system that is buoyant in gastric fluid
Inventor: TALWAR NARESH
IPC: A61K47/30
Filed: 2000-08-01
Abstract: Described is a gastro-retentive oral drug delivery system structurally comprised of a highly porous matrix comprising a drug, gas generating components, sugar, release controlling agents and, optionally, spheronising agents. The pharmaceutical composition, either in the form of pellets (multiparticulate or single unit dosage form), beads, granules or capsules, is retained in the stomach while selectively delivering the drug at the gastric levels and upper parts of small intestine over an extended period of time.
Patent NZ-517175-A (NZ)
Title: Cork extractor
Inventor: GELBARD MARTIN K
IPC: B67B7/10
Filed: 2000-07-12
Abstract: An extractor (10) removes cork from the inside of a main body of a narrow neck bottle. In one version, the extractor comprises a handle (12), and at least two generally oval wire loops (14a, 14b) depending from the handle, the wire loops being deformable so they can fit through the neck and expand and capture a cork. Optionally, mesh is provided with the loops for extracting cork fragments. In another version, the extractor comprises a housing with a chamber therein, and a flexible elongated leg retractable into the housing. The leg has mesh secured to it for capturing cork pieces.
Patent NZ-520899-A (NZ)
Title: Treatment of fungal infections with polyene or beta glucan synthase inhibitor antifungals combined with anti HSP90 antibodies
Inventor: BURNIE JAMES PETER
IPC: A61K47/48
Filed: 2001-03-20
Abstract: The use of a composition comprising an antibody or an antigen binding fragment thereof specific for one or more epitopes of a fungal stress protein and an antifungal agent comprising at least one of the group consisting of a polyene antifungal agent and an echinocandin antiftngal agent in a method of manufacture of a medicarnent for the treatment of fungal infections, wherein the fungus causing said fingal infection is resistant to said antifungal agent per se.
Patent NZ-526274-A (NZ)
Title: Grate structure for solid fuel burners
Inventor: WILLIAMS PAUL DOUGLAS
IPC: C10J3/72
Filed: 2001-12-21
Abstract: In one aspect, a grate segment for a burner, comprises a substantially rigid body (30) having a dispersed array of cavities (38) filled with a refractory material. In another aspect, a solid fuel gasifier includes a housing (12) defining a gasifier chamber (14), and a solid fuel inlet (21), grate structure (22, 24)in the gasifier chamber. The grate structure includes base means, a plurality of agitator segments (32) positioned relative to the base means for reciprocating movement to agitate a fuel load in the gasifier, and means to support the base means and the agitator segments so that the latter reciprocate in a direction at a substantial inclination to both horizontal and vertical. In use of the gasifier a deep burden of fuel accumulates on the grate structure and the outward stroke of the reciprocation of the agitator elements is in the overall direction of flow of the fuel burden or generally oppositely thereto.
Patent NZ-527276-A (NZ)
Title: 1,2,3,4-tetrahydroisoquinoline derivatives as urotensin II receptor antagonists
Inventor: VELKER JORG
IPC: C07D491/04
Filed: 2002-03-20
Abstract: Disclosed herein are 1,2,3,4-tetrahydroisoquinoline derivatives of formula (I) and related compounds and their use as active ingredients in the preparation of pharmaceutical compositions. Processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as neurohormonal antagonists especially urotensin II antagonists are also disclosed.
Patent NZ-531589-A (NZ)
Title: Microbial polynucleotides expressed during infection of a host
Inventor: PROGULSKE-FOX ANN
IPC: C12Q1/6809
Filed: 2000-08-04
Abstract: A method of confirming an animal model of microbial infection as a valid model comprising the steps of: (a) adsorbing a first sera sample from one or more animal model hosts infected with or previously infected with a microbe, with cells or cellular extracts of the microbe that have been grown in vitro; (b) adsorbing a second sera sample from one or more second hosts infected with or previously infected with the microbe, with cells or cellular extracts of the microbe that have been grown in vitro; wherein the second host is a different species of animal than the animal model host; (c) isolating unadsorbed antibodies from the first serum sample and from the second serum sample; (d) probing a first expression library of the microbe with the unadsorbed antibodies from the first serum sample, and probing a second expression library with the unadsorbed antibodies from the second serum sample, wherein polynucleotides of the microbe that are expressed in vivo are identified for the first and second serum sample; and e comparing the polynucleotides of the microbe that are expressed in vivo in the animal model host and the second host; wherein if the polynucleotides expressed in vivo in the animal model and in the second host are the same or similar, then the animal model is confirmed as a valid model. (62) Divided out of 515553
Patent NZ-531603-A (NZ)
Title: A method of controlling feed variation in a valuable mineral flotation circuit
Inventor: PALOSAARI VEIKKO
IPC: B03D1/02
Filed: 2002-09-20
Abstract: A method of controlling the content of minerals that float naturally in the feed of a concentration plant flotation circuit processing valuable minerals, characterised in that after grinding, rougher floatation (l) is performed on minerals that float naturally into what is termed rougher concentrate, which is then stored. The tailing of rougher concentration forms the main feed of the valuable minerals floatation circuit (ll), to which the rougher concentrate is added as a pre-measured flow before flotation.
Patent NZ-533668-A (NZ)
Title: Solder ring for production of vacuum tube and method for the production of such a solder ring and of a vacuum tube
Inventor: HILDERINK JOHANNES HERMANNUS L
IPC: B23K3/06
Filed: 2002-12-23
Abstract: A solder ring (12) for joining two components (10, 11) of a vacuum tube, the solder ring comprising a joining part that consists of solder material for forming an airtight joint between the two components. The solder ring further comprises at least one centring part. The centring part has at least one first projection (14, 15) that extends on one side of the joining part essentially in an axial direction of the solder ring and at least one second projection (13, 16) that extends in an opposing direction for centring the two components with respect to one another.
Patent NZ-533850-A (NZ)
Title: Communication assistance system and method
Inventor: PINES ROBERT
IPC: H04M3/51
Filed: 2002-12-31
Abstract: A communication assistance system is disclosed. The communication assistance system comprises: (a) a first database (18) that has a plurality of listings therein, where each of the listings has at least one contact name and a corresponding contact number, (b) a switching device (12) configured to direct a communication from a telephone device (6) of a user to the system, and (c) a past requested listing table for at least one of the users of the system, which is configured to store prior requested listings obtained from the database (18), wherein when the user contacts the system with the telephone device (6), the system recognizes the user and retrieves at least a portion of the stored prior requested listings from the past requested listing table and delivers them to a customer service representative at an operator terminal (20) of the system.
Patent NZ-537774-A (NZ)
Title: Pharmaceutical preparation and method of treatment of human malignancies with a composition comprising recombinant human arginase produced by fermentation of transformed Bacillus substilis
Inventor: LO WAI HUNG
IPC: A61K38/00
Filed: 2003-06-20
Abstract: An isolated recombinant human arginase I comprising modification resulting in an in vitro plasma half-life of at least three days. Also described is a pharmaceutical composition comprising the isolated and substantially purified recombinant human arginase I and the use of the recombinant human arginase I for the preparation of a medicament which can be used for the treatment of malignancies.
Patent NZ-537947-A (NZ)
Title: Method for producing highly pure hydroxy indolyl glyoxylic acid amides
Inventor: JANSCH HANS-JOACHIM
IPC: C07D401/12
Filed: 2003-07-31
Abstract: A process for preparing hydroxyindol-3-ylglyoxylamides of the formula (I) is disclosed wherein the variables are as defined in the specification, in which indoles are converted by reaction with oxalyl halides into indol-3-ylglyoxylyl halides which are then converted by reaction with ammonia or with primary or secondary amines into the hydroxyindol-3-ylglyoxylamides of the formula (I), wherein 5-benzyloxyindole, 6-benzyloxyindole or 5,6-dibenzyloxyindole is used as starting material.
Patent NZ-539502-A (NZ)
Title: Line and tackle securing device
Inventor: MASSIMINO SALVATORE
IPC: A01K97/06
Filed: 2003-09-19
Abstract: A securing device for securing a line and/or fishing tackle to a fishing rod. the securing device comprising a body, a first aperture (11) in the body adapted to engage the fishing rod and a second aperture (12) in the body spaced from the first aperture (11) and adapted to releasably engage the fishing line and/or an item of fishing tackle. The device may be formed with holes to receive hooks, and is preferably buoyant and formed in bright colours. A method of securing a line is also described.